Medicare Enrolled

Dr. Michael Rosario-Prieto, MD

Neuromuscular Medicine (Psychiatry & Neurology) Physician · St Petersburg, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
1201 5TH AVE N, St Petersburg, FL 33705
7278207701
In practice since 2008 (17 years)
NPI: 1871738948 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rosario-Prieto from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rosario-Prieto? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rosario-Prieto

Dr. Michael Rosario-Prieto is a neuromuscular medicine (psychiatry & neurology) physician in St Petersburg, FL, with 17 years in practice. Based on federal Medicare data, Dr. Rosario-Prieto performed 7,089 Medicare services across 460 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rosario-Prieto received a total of $118,940 from 72 pharmaceutical and/or device companies across 740 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neuromuscular medicine (psychiatry & neurology) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rosario-Prieto is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 12% volume in FL$ $118,940 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,089
Medicare services
Top 12% in FL for neuromuscular medicine (psychiatry & neurology) physician
460
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~417 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit6,449$5$13
Office visit, established patient (30-39 min)122$89$311
Injection, methylprednisolone acetate, 40 mg108$5$15
Office visit, established patient, complex (40-54 min)70$129$436
Hospital follow-up visit, moderate complexity66$63$179
Needle measurement of electrical activity in arm or leg muscles, complete study50$74$233
Hospital follow-up visit, high complexity32$92$257
Injection of anesthetic agent and/or steroid into upper neck and back of head nerve29$77$188
Office visit, established patient (20-29 min)27$57$221
New patient office visit (45-59 min)26$122$408
Initial hospital admission, high complexity26$127$498
New patient office visit, complex (60-74 min)25$159$539
Needle measurement of electrical activity in arm or leg muscles, limited study22$45$146
Nerve conduction, 9-10 studies15$161$510
Nerve conduction, 7-8 studies11$123$420
Nerve conduction, 13 or more studies11$220$689
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$118,940
Total received (2018-2024)
Avg $16,991/year across 7 years
Top 12% in FL for neuromuscular medicine (psychiatry & neurology) physician
72
Companies
740
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$100,538 (84.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,121 (10.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,281 (5.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$76,001
2023
$24,979
2022
$11,681
2021
$1,200
2020
$705
2019
$2,144
2018
$2,231

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$61,928
ARGENX US, INC.
$37,676
UCB SA
$3,995
Amgen Inc.
$2,471
Alexion Pharmaceuticals, Inc.
$1,578
Piramal Critical Care
$886
Novartis Pharmaceuticals Corporation
$682
Teva Pharmaceuticals USA, Inc.
$575
ABBVIE INC.
$556
Genentech USA, Inc.
$543
Allergan, Inc.
$480
Biogen, Inc.
$461
Takeda Pharmaceuticals U.S.A., Inc.
$446
MITSUBISHI TANABE PHARMA AMERICA, INC.
$394
AbbVie Inc.
$391
Allergan Inc.
$377
PFIZER INC.
$360
CSL Behring
$342
Lilly USA, LLC
$327
Neurocrine Biosciences, Inc.
$308
GE HealthCare
$304
Lundbeck LLC
$287
Acorda Therapeutics, Inc
$284
SK Life Science, Inc.
$242
GE HEALTHCARE
$200
ACADIA Pharmaceuticals Inc
$188
Eisai Inc.
$166
Sunovion Pharmaceuticals Inc.
$161
PORTOLA PHARMACEUTICALS, INC.
$159
Sumitomo Pharma America, Inc.
$147
Silk Road Medical, Inc.
$138
CATALYST PHARMACEUTICALS, INC.
$137
Supernus Pharmaceuticals, Inc.
$131
GENZYME CORPORATION
$122
EMD Serono, Inc.
$94
Upsher-Smith Laboratories LLC
$94
Merz Pharmaceuticals, LLC
$92
Sarepta Therapeutics, Inc.
$82
Grifols USA, LLC
$74
BANNER LIFE SCIENCES, LLC
$72
Jazz Pharmaceuticals Inc.
$68
Alnylam Pharmaceuticals Inc.
$67
Biohaven Pharmaceutical Holding Company Ltd.
$66
Xeris Pharmaceuticals, Inc.
$65
Vanda Pharmaceuticals Inc.
$62
AstraZeneca Pharmaceuticals LP
$61
Neurelis, Inc.
$40
Avanir Pharmaceuticals, Inc.
$39
Biohaven Pharmaceuticals, Inc.
$38
Horizon Pharma plc
$32
Catalyst Pharmaceuticals, Inc.
$32
Harmony Biosciences LLC
$30
Bayer HealthCare Pharmaceuticals Inc.
$28
Zyla Life Sciences, Inc.
$28
UPSHER-SMITH LABORATORIES LLC
$26
US WorldMeds, LLC
$26
Egalet US Inc
$24
Banner Life Sciences, LLC
$24
JAZZ PHARMACEUTICALS INC.
$24
Vertical Pharmaceuticals, LLC
$21
LivaNova USA, Inc.
$20
EISAI INC.
$19
Corium, LLC
$19
ITF Therapeutics LLC
$17
Promius Pharma LLC
$17
Amylyx Pharmaceuticals, Inc.
$17
IDORSIA PHARMACEUTICALS US INC
$16
Kyowa Kirin, Inc.
$16
Celgene Corporation
$13
PTC Therapeutics, Inc.
$13
PORTOLA PHARMACEUTICALS, LLC
$12
Aucta Pharmaceuticals, Inc.
$12
Top 3 companies account for 87.1% of total payments
Associated products mentioned in payments ›
AFINITOR · AGAMREE · AIMOVIG · AJOVY · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · Actemra · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · COMIRNATY · COPAXONE · EMFLAZA · EMGALITY · ENROUTE Transcarotid Neuroprotection System · EPIDIOLEX · EVUSHELD · Elevidys · Evrysdi · Exondys 51 · FIRDAPSE · Fintepla · Fycompa · GABLOFEN 1 mL in 1 SYRINGE · GAMMAGARD · GILENYA · GLASS · GVOKE PFS · Gamunex-C · HYQVIA · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · LEMTRADA · LUMIZYME · Leqembi · MAYZENT · MYOBLOC · Mavenclad · Motpoly XR · NAMZARIC · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · Ocrevus · Ongentys · PANZYGA · PAXLOVID · PONVORY · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · RADICAVA · RAYOS · RELEXXII · RELYVRIO · REXULTI · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · Soliris · TAVNEOS · TECFIDERA · TOPIRAMATE Extended Release Capsules · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · XCOPRI · XYREM · XYWAV · Xeomin · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (84%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neuromuscular medicine (psychiatry & neurology) physician and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $1,678 per 100 Medicare services performed
Looking for a neuromuscular medicine (psychiatry & neurology) physician in St Petersburg?
Compare neuromuscular medicine (psychiatry & neurology) physicians in the St Petersburg area by procedure volume, costs, and industry payment transparency.
Browse neuromuscular medicine (psychiatry & neurology) physicians nearby

Geographic Context

Neuromuscular Medicine (Psychiatry & Neurology) Physicians within 10 mi
1
Per 100K population
0.1
County median income
$70,293
Nearest hospital
ST ANTHONYS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rosario-Prieto is a mixed practice specialist, with above-average Medicare volume (top 12% in FL), and high industry engagement (speaking/promotional, top 12%), with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rosario-Prieto experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Rosario-Prieto performed 6,449 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rosario-Prieto receive payments from pharmaceutical companies?
Yes. Dr. Rosario-Prieto received a total of $118,940 from 72 companies across 740 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rosario-Prieto's costs compare to other neuromuscular medicine (psychiatry & neurology) physicians in St Petersburg?
Dr. Rosario-Prieto's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rosario-Prieto) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →